Literature DB >> 18209097

Induction of CD56 and TCR-independent activation of T cells with aging.

Bonnie H Lemster1, Joshua J Michel, David T Montag, John J Paat, Stephanie A Studenski, Anne B Newman, Abbe N Vallejo.   

Abstract

Degeneration of the thymus and severe contraction of the T cell repertoire with aging suggest that immune homeostasis in old age could be mediated by distinct effectors. Therefore, receptors expressed on T cells as they undergo senescence in vitro, as well as those displayed by circulating T cells during normal chronologic aging, were examined. Monitoring of T cells driven to senescence showed de novo induction of CD56, the prototypic receptor of NK cells. Analysis of fresh T cells in peripheral blood showed an age-dependent induction of CD56. These unusual T cells expressed high levels of Bcl2, p16, and p53, and had limited, or completely lost, ability to undergo cell division, properties consistent with senescence. CD56 cross-linking without TCR ligation on CD56(+) T cells resulted in extensive protein phosphorylation, NF-kappaB activation, and Bax down-regulation. CD56 cross-linking was also sufficient to drive production of various humoral factors. These data suggest that the immunologic environment in old age is functionally distinct, rather than being a dysfunctional version of that seen at a young age. CD56(+) T cells are unique effectors capable of mediating TCR-independent immune cascades that could be harnessed to enhance protective immunity in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209097     DOI: 10.4049/jimmunol.180.3.1979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Integration of immunity with physical and cognitive function in definitions of successful aging.

Authors:  Patricia Griffin; Joshua J Michel; Kristy Huysman; Alison J Logar; Abbe N Vallejo
Journal:  Aging Dis       Date:  2012-02-27       Impact factor: 6.745

2.  Finding Balance: T cell Regulatory Receptor Expression during Aging.

Authors:  Mary M Cavanagh; Qian Qi; Cornelia M Weyand; Jörg J Goronzy
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 3.  Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Clin Immunol       Date:  2010-08-19       Impact factor: 8.317

Review 4.  Forging a signature of in vivo senescence.

Authors:  Norman E Sharpless; Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

5.  Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy.

Authors:  Julie A E Nelson; Janakiraman Krishnamurthy; Prema Menezes; Yan Liu; Michael G Hudgens; Norman E Sharpless; Joseph J Eron
Journal:  Aging Cell       Date:  2012-10       Impact factor: 9.304

6.  Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects.

Authors:  Mazen Almehmadi; Brian F Flanagan; Naeem Khan; Suliman Alomar; Stephen E Christmas
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 7.  Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.

Authors:  Elizabeth M Urban; Andrei I Chapoval; C David Pauza
Journal:  Clin Dev Immunol       Date:  2010-04-13

8.  Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.

Authors:  Rifca Le Dieu; David C Taussig; Alan G Ramsay; Richard Mitter; Faridah Miraki-Moud; Rewas Fatah; Abigail M Lee; T Andrew Lister; John G Gribben
Journal:  Blood       Date:  2009-08-26       Impact factor: 22.113

9.  Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.

Authors:  Christin E Burd; Jessica A Sorrentino; Kelly S Clark; David B Darr; Janakiraman Krishnamurthy; Allison M Deal; Nabeel Bardeesy; Diego H Castrillon; David H Beach; Norman E Sharpless
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

10.  Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells.

Authors:  Elizabeth M Urban; Haishan Li; Cheryl Armstrong; Chiara Focaccetti; Cristiana Cairo; C David Pauza
Journal:  BMC Immunol       Date:  2009-09-21       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.